Combining Nucleotides with Fish Oils and L-Arginine before surgery prevents infections in colon cancer patients
Researchers in the Department of Surgery, School of Medicine, Jichi Medical University in Japan performed a prospective (forward looking study) in patients slated for surgery to remove their colon cancer. 33 patients were placed on Immunonutrition for the 5 days before surgery and 34 patients served as the control group and didn?t receive the supplement. It is important to know that none of the participants in either group were malnourished. The Immunonutrition consisted of Nucleotides in conjunction with Fish Oils and L:-Arginine. None of the patients on Immunonutrition developed an infection at the site of surgery but 12% of the non-supplemented group did with an additional 3% developing an infection in an organ; that?s 15% developing infection due to surgery if not supplemented with Immunonutrition. Published electronically ahead of print December 25th, 2006 in the journal Surgery Today.
Celebrex with Turmeric could greatly reduce the risk of colon cancer
A number of studies have shown that COX-2 enzyme inhibitors may prevent colorectal cancer. However, the long-term use of COX-2 inhibitors may lead to toxicity and use may be limited by cardiovascular side effects. A number of studies have shown that COX-2 enzyme inhibitors may prevent colorectal cancer. However, the long-term use of COX-2 inhibitors may lead to toxicity and use may be limited due to its cardiovascular side effects.
Male rats were injected with a chemical that causes colon cancer. This chemical is highly toxic and a known carcinogen. The rats were then given either regular chow, chow with Curcumin, Chow with celecoxib (Celebrex), or chow with both celecoxib and Curcumin. The number of abnormal-pre-colon cancer cells in the rats with regular chow averaged 64. 47 in the celecoxib group, and 39 in the Curcumin group. However in rats fed both celecoxib and Curcumin there were only 24 abnormal cells. The results were important because 100mg of Celebrex ion conjunction with Turmeric supplements easily achieve this ability to inhibit the growth of precancerous colon cells in humans. The study is published in the January 2006 issue of the journal Digestion.